| Intrinsic apoptosis | Extrinsic apoptosis | Necrosis | Necroptosis | Ferroptosis | Pyroptosis | Refs. |
---|---|---|---|---|---|---|---|
Initiators | Loss of growth factor signals, DNA damage, reactive oxygen species (ROS) excess, hypoxia, chemotherapeutic medicines | Extracellular microenvironment, TNF-α, FasL (death ligand binds its receptor), and infectious pathogens | Toxins, infections, trauma | Ischemic injury, FASL, TNFR1 | Erastin, RSL3, iron accumulation and lipid peroxidation, | LPS, DAMPs, microbial infections | |
Intermediate signalings | Mitochondrial pathway Caspase-3, -6, -7, -9-dependent | Caspase-3, -8-dependent | Danger signals, ROS | Caspase-independent RIP1/RIP3/MLKL necrosome | Iron-dependent production of ROS | Nod-like receptors (NLRP3) Caspase 1-dependent pyroptosome, caspase-4/5/11 | [193] |
Morphological features | Retention of plasma membrane integrity, cell shrinkage, DNA fragmentation, phosphatidylserine (PS) exposure, and the formation of apoptotic bodies | Retention of plasma membrane integrity, cell shrinkage, DNA fragmentation, phosphatidylserine (PS) exposure, and the formation of apoptotic bodies | Loss of plasma membrane integrity, cell swelling, leak of content | Membrane permeabilization, swollen cellular organelles | Cytoplasmic swelling (oncosis), chromatin condensation, swelling of cytoplasmic organelles and loss of membrane integrity | Pore formation, swelling of cell, rapid loss of plasma membrane | |
DAMPs released | CRT, ATP (at pre-apoptotic stage), HMGB1(at late-apoptotic stage), histones, Annexin A1 (ANXA1) | CRT, ATP, HMGB1, histones (release of nuclear DAMPs following DNA fragmentation), Annexin A1 (ANXA1) | HMGB1, ATP, histones, HSPs | ATP, CRT, | HMGB1, DNA, lipid oxidation products such as 4HNE, LTB4, LTC4, LTD4 and PGE2 | ATP, HMGB1 | |
Inflammation | Non-inflammatory | Non-inflammatory | Pro-inflammatory | Pro-inflammatory | Pro-inflammatory | Pro-inflammatory | Â |
Immunogenicity | Non-immunogenic (may be immunogenic under stress situations like chemotherapy or physical modalities) | Non-immunogenic (may be immunogenic under stress situations like chemotherapy or physical modalities) | Very high | High | High | High | [27] |